MedPath
HSA Approval

VERRUMAL SOLUTION

SIN04266P

VERRUMAL SOLUTION

VERRUMAL SOLUTION

April 30, 1990

ZUELLIG PHARMA PTE. LTD.

ZUELLIG PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZUELLIG PHARMA PTE. LTD.
Licence HolderZUELLIG PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION

TOPICAL

Medical Information

D11AF

疣和鸡眼治疗药

Manufacturer Information

ZUELLIG PHARMA PTE. LTD.

ALMIRALL HERMAL GmbH

Active Ingredients

DIMETHYL SULPHOXIDE

8 g/100 g

Dimethyl Sulfoxide

SALICYLIC ACID

10 g/100 g

Salicylic acid

FLUOROURACIL

0.5 g/100 g

Fluorouracil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VERRUMAL SOLUTION - HSA Approval | MedPath